Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
about
Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public HealthWhen 1+1>2: Nanostructured composites for hard tissue engineering applicationsUltrasound treatment increases transfection efficiency of low molecular weight chitosan in fibroblasts but not in KB cells.Chitosan Grafted with Phosphorylcholine and Macrocyclic Polyamine as an Effective Gene Delivery Vector: Preparation, Characterization and In Vitro Transfection.In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.Chitosan hydrogel as siRNA vector for prolonged gene silencing.Low power, biologically benign NIR light triggers polymer disassembly.Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.Application of chitosan-based nanocarriers in tumor-targeted drug delivery.A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral VectorTetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.Polypeptides and polyaminoacids in drug delivery.Chitosan nanoparticles: a survey of preparation methods.Topical drug delivery using chitosan nano- and microparticles.Nanobiotechnology-based strategies for crossing the blood-brain barrier.Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy.Therapeutic gold, silver, and platinum nanoparticles.Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification.Preparation and characterization of gelatin nanoparticles containing pDNA encoding IL-12 and their expression in CT-26 carcinoma cells.Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review.Development of a low toxicity, effective pDNA vector based on noncovalent assembly of bioresponsive amino-β-cyclodextrin:adamantane-poly(vinyl alcohol)-poly(ethylene glycol) transfection complexes.Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells.Chitosan and its derivatives as vehicles for drug delivery.The Immunogenicity of CRISP1 Plasmid-Based Contraceptive Vaccine can be Improved When Using Chitosan Nanoparticles as the Carrier.Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation.Nanoparticles and Controlled Delivery for Bioactive Compounds: Outlining Challenges for New "Smart-Foods" for Health.In vivo methods for acute modulation of gene expression in the central nervous systemParticulate transepithelial drug carriers: barriers and functional polymersChitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for Pulmonary Drug DeliveryChitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD
P2860
Q28384520-A3557398-20CE-4BCB-BEA8-FA1C268757D5Q30368848-8BB50D8C-A497-4D86-880B-2617A8F8A934Q30441211-A2B264DB-69FD-4559-91CE-BF562261D1E4Q30914499-48A7DD58-8BE0-4720-BAD0-26171A64A52AQ33709398-A615CC94-E04E-4FEF-80F0-62CFA0D9C800Q33925196-71FCC982-2D99-452A-B101-6DDB2A2D5BECQ34077608-6D2AE0E3-DEEC-4F2E-B2D5-6700D7197C8EQ34080235-83D1BABC-4586-4736-ACC8-618BDA1821B3Q34447152-AF75C0E5-3C4A-4A52-9618-88E1823C4E6DQ36969493-847E8C47-1215-46C9-8A54-64ABCCDE2697Q37302933-DE3C0C69-D54F-4BE4-BB0D-C97BEB072B06Q37584464-AF814BAD-4796-490E-BF57-3ACAFA873AD2Q37947952-F0DF113B-75B1-4DBA-B557-C6DA39E2B168Q37975554-4F8EBB80-C465-450A-B539-2333E15A470CQ37980520-2D58039F-9253-4DCB-8202-D48FAFEF8739Q38024402-C4913368-40D6-4A7A-8B42-826481EE5CF2Q38038895-3C42FA71-FF4E-4ECD-B6BA-3A23336CB943Q38123458-8E0FDF5C-5C6A-4D90-8E0E-BEB0E0CC1965Q38292983-82253CFC-CA11-4B35-BA06-709D5BBE69DDQ38384069-852070CB-DAC9-471B-9508-9BDA1C4A5328Q39029692-52A37AC6-CFE7-4C8E-8EC8-9E33A83C7BF5Q39117561-71E32C86-43EC-4804-AAF2-B1EF6A69C504Q39209049-94DAE394-B710-4E12-BBED-FAFC7514E6B5Q42272223-86BB3930-CA09-4A1C-ACEE-27DA70978337Q44727606-342206CD-7AE4-4EEB-8FD4-19360EBD765EQ50073720-FD5E3E8A-07B1-431B-9C3B-EF0E388C35FEQ50905925-AEDB0B94-265F-4EB5-9B77-BCF2FDB7CFADQ53672357-EAABE8FA-7454-4A51-97A7-8A31C13D546FQ55252923-E8E37B39-D3BB-45FA-B628-1AAA7395C78BQ57020987-4AC8AC8B-0DC0-4589-A346-CC1C541D1551Q58385253-50A0FC1B-0E47-46EA-803F-A1673B805EEFQ58655855-482FD6D8-09B8-421E-B756-F71BB8D65D33Q58765669-68887AA1-E544-46A3-A5F1-0C7EBE04341C
P2860
Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in using chitosan-bas ...... n vivo drug and gene delivery.
@en
Advances in using chitosan-bas ...... n vivo drug and gene delivery.
@nl
type
label
Advances in using chitosan-bas ...... n vivo drug and gene delivery.
@en
Advances in using chitosan-bas ...... n vivo drug and gene delivery.
@nl
prefLabel
Advances in using chitosan-bas ...... n vivo drug and gene delivery.
@en
Advances in using chitosan-bas ...... n vivo drug and gene delivery.
@nl
P2860
P1476
Advances in using chitosan-bas ...... n vivo drug and gene delivery.
@en
P2093
Maryam Tabrizian
Nicolas Duceppe
P2860
P304
P356
10.1517/17425247.2010.514604
P407
P577
2010-10-01T00:00:00Z